You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

3,4 diaminopyridine

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Congenital Myasthenic Syndrome Trial in Sacramento (3,4-Diaminopyridine)

Available
  • Congenital Myasthenic Syndrome
  • 3,4-Diaminopyridine
  • Sacramento, California
    University of California, Davis Medical Center
Apr 18, 2022

Myasthenic Syndromes, Congenital Trial in Durham (3,4-diaminopyridine)

No longer available
  • Myasthenic Syndromes, Congenital
  • 3,4-diaminopyridine
  • Durham, North Carolina
    Duke University Hospital
Jan 3, 2022

Lambert Eaton Myasthenic Syndrome Trial in Aurora (3, 4-Diaminopyridine)

Approved for marketing
  • Lambert Eaton Myasthenic Syndrome
  • 3, 4-Diaminopyridine
  • Aurora, Colorado
    University of Colorado
Sep 28, 2021

Brugada Syndrome Trial in Paris (3,4-Di-amino-Pyridine, )

Terminated
  • Brugada Syndrome
  • Paris, France
    Lariboisière University Hospital - Cardiology department
Dec 3, 2020

Myasthenic Syndromes, Congenital Trial in United States (amifampridine phosphate, Placebo)

Completed
Has Results
  • Myasthenic Syndromes, Congenital
  • amifampridine phosphate
  • Placebo
  • Los Angeles, California
  • +3 more
Mar 8, 2021

Muscular Atrophy, Spinal Trial in Milano (Amifampridine Phosphate, Placebo Oral Tablet)

Completed
Has Results
  • Muscular Atrophy, Spinal
  • Amifampridine Phosphate
  • Placebo Oral Tablet
  • Milano, Lombardy, Italy
    Neurological Institute Carlo Besta
May 28, 2021

Lambert-Eaton Myasthenic Syndrome (LEMS), Congenital Myasthenia (CM) Trial in Portland (3,4-diaminopyridine)

No longer available
  • Lambert-Eaton Myasthenic Syndrome (LEMS)
  • Congenital Myasthenia (CM)
  • 3,4-diaminopyridine
  • Portland, Oregon
    Oregon Health & Science University
Dec 9, 2019

Lambert Eaton Myasthenic Syndrome Trial in Sacramento (3, 4 DAP)

No longer available
  • Lambert Eaton Myasthenic Syndrome
  • 3, 4 DAP
  • Sacramento, California
    University of California, Davis
Oct 28, 2019

Lambert-Eaton Myasthenic Syndrome Trial (3,4 diaminopyridine)

No longer available
  • Lambert-Eaton Myasthenic Syndrome
  • 3,4 diaminopyridine
  • (no location specified)
Jul 5, 2019

Healthy Trial in Basel (MDMA 120 mg + MDMA 60 mg, MDMA 120 mg + , Placebo)

Not yet recruiting
  • Healthy
  • MDMA 120 mg + MDMA 60 mg
  • +2 more
  • Basel, Switzerland
    University Hospital
Mar 28, 2023

Congenital Myasthenic Syndrome Trial in Los Angeles (Amifampridine Phosphate)

No longer available
  • Congenital Myasthenic Syndrome
  • Amifampridine Phosphate
  • Los Angeles, California
    UCLA
Dec 5, 2019

Muscle Weakness Trial in Lebanon (3-4 Diaminopyridine)

Terminated
Has Results
  • Muscle Weakness
  • 3-4 Diaminopyridine
  • Lebanon, New Hampshire
    Dartmouth-Hitchcock Medical Center
May 1, 2019

Healthy Trial (3,4-methylenedioxymethamphetamine, S-3,4-methylenedioxymethamphetamine, R-3,4-methylenedioxymethamphetamine (125

Recruiting
  • Healthy
  • Basel, Switzerland
    University Hospital Basel
Nov 1, 2022

Diabetes Type 2 With Proteinuria, Diabetes, Type 2, Diabetes Trial (drug, device, diagnostic test, behavioral)

Not yet recruiting
  • Diabetes Mellitus Type 2 With Proteinuria
  • +12 more
  • Empagliflozin 10 MG
  • +6 more
  • (no location specified)
Oct 17, 2023

Nasal Decolonization of Staphylococcus Aureus Trial in Uppsala (Vehicle gel, 4 + 4 applications or 4 + 2 applications, LTX-109

Completed
  • Nasal Decolonization of Staphylococcus Aureus
  • Vehicle gel, 4 + 4 applications or 4 + 2 applications
  • +2 more
  • Uppsala, Sweden
    ClinSmart Sweden AB
May 25, 2023

Melasma Trial in Jakarta (3 % Topical Tranexamic Acid, 4% Topical Hidroquinone)

Recruiting
  • Melasma
  • 3 % Topical Tranexamic Acid
  • 4% Topical Hidroquinone
  • Jakarta, DKI Jakarta, Indonesia
    Cipto Mangungkusumo Hospital
Aug 21, 2023

Symptomatic Irreversible Pulpitis Trial (3.6 ml 4% Articaine HCl, 1.8 ml 4% Articaine HCl)

Not yet recruiting
  • Symptomatic Irreversible Pulpitis
  • 3.6 ml 4% Articaine hydrochloride
  • 1.8 ml 4% Articaine hydrochloride
  • (no location specified)
Nov 3, 2023

Primary Knee Osteoarthritis Grade 3 - 4 Trial in Tbilisi (Lipocet® (food supplement), Lipocet Placebo)

Completed
  • Primary Knee Osteoarthritis Grade 3 - 4
  • Lipocet® (food supplement)
  • Lipocet Placebo
  • Tbilisi, Georgia
  • +2 more
Nov 10, 2023

Bipolar Disorder Trial in Canada (Cannabidiol, Placebo)

Not yet recruiting
  • Bipolar Disorder
  • Calgary, Alberta, Canada
  • +7 more
May 18, 2023

Healthy Trial in Basel (3,4-methylenedioxymethamphetamine, 3,4-methylenedioxyamphetamine,

Recruiting
  • Healthy
  • Basel, BS, Switzerland
    University Hospital Basel, Clinical Trial Unit
Dec 7, 2021

Smallpox, Monkeypox, Cowpox Trial in Novosibirsk (NIOCH-14, 200 mg capsule: 1 capsule (200 mg) of NIOCH-14 once orally,

Completed
  • Smallpox
  • +3 more
  • NIOCH-14, 200 mg capsule: 1 capsule (200 mg) of NIOCH-14 once orally
  • +5 more
  • Novosibirsk, Koltsovo, Novosibirsk Region, Russian Federation
    Federal State Budgetary Healthcare Institution - Medical and San
Jul 27, 2023

Prostate Cancer Trial ([99mTc]Tc-PSMA-T4)

Not yet recruiting
  • Prostate Cancer
  • [99mTc]Tc-PSMA-T4
  • (no location specified)
Apr 26, 2023

Laparoscopy Trial in Basel (Gastric bypass surgery with 2D 4K laparoscopic imaging, Gastric bypass surgery with 3D HD

Not yet recruiting
  • Laparoscopy
  • Gastric bypass surgery with 2D 4K laparoscopic imaging
  • Gastric bypass surgery with 3D HD laparoscopic imaging
  • Basel, Switzerland
    Clarunis University Center for Gastrointestinal and Liver Diseas
May 30, 2023

Local Anesthetic Trial (Chloroprocaine 3% eye gel, Oxybuprocaine Hydrochloride 4 Mg/mL Eye Drops)

Not yet recruiting
  • Local Anesthetic
  • Chloroprocaine 3% eye gel
  • Oxybuprocaine Hydrochloride 4 Mg/mL Eye Drops
  • (no location specified)
Jun 27, 2023

CYP3A4*22 Trial (Palbociclib 125Mg Tab, Ribociclib 200Mg Oral Tablet, Abemaciclib 150 MG Oral Tablet)

Not yet recruiting
  • CYP3A4*22
  • Palbociclib 125Mg Tab
  • +2 more
  • (no location specified)
Jan 10, 2023